Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 6,142 | $10.04 | 189,755 | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 17,896 | $12.28 | 207,651 | |
| Jul 09, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 44,447 | $15.92 | 163,204 | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 11,559 | -- | -- | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 8,850 | -- | -- | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 6,142 | -- | 55,099 | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 17,896 | -- | -- | |
| Jul 10, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 28,843 | $5.13 | 192,047 | |
| Jul 10, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 28,843 | $15.65 | 163,204 | |
| Jul 10, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 28,843 | -- | 11,778 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.